B-type natriuretic peptide predicts cardiac morbidity and mortality after major surgery
- 2 March 2007
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 94 (7), 903-909
- https://doi.org/10.1002/bjs.5690
Abstract
Background The objective of this study was to determine whether measurement of B-type natriuretic peptide (BNP) concentration before operation could be used to predict perioperative cardiac morbidity. Methods A prospective derivation study was performed in high-risk patients undergoing major non-cardiac surgery, with a subsequent validation study. A venous blood sample was taken the day before surgery for measurement of plasma BNP concentration. Screening for cardiac events (non-fatal myocardial infarction and cardiac death) was performed using clinical criteria, cardiac troponin I analysis and serial electrocardiography. Results Forty-one patients were recruited to the derivation cohort and 149 to the validation cohort. In the derivation cohort, the median (interquartile range) BNP concentration in the 11 patients who had a postoperative cardiac event was 210 (165–380) pg/ml, compared with 34·5 (14–70) pg/ml in those with no cardiac complications (P < 0·001). In the validation cohort, the median BNP concentration in the 15 patients who had a cardiac event was 351 (127–1034) pg/ml, compared with 30·5 (11–79·5) pg/ml in the remainder (P < 0·001). BNP concentration remained a significant outcome predictor in multivariable analysis (P < 0·001). Using receiver–operator curve analysis it was calculated that a BNP concentration of 108·5 pg/ml best predicted the likelihood of cardiac events, with a sensitivity and specificity of 87 per cent each. Conclusion Preoperative serum BNP concentration predicted postoperative cardiac events in patients undergoing major non-cardiac surgery independently of other risk factors.Keywords
This publication has 25 references indexed in Scilit:
- Preoperative plasma N-terminal pro-brain natriuretic peptide as a marker of cardiac risk in patients undergoing elective non-cardiac surgery (Br J Surg 2005; 92: 1041-1045)British Journal of Surgery, 2005
- A Combination of Statins and Beta-blockers is Independently Associated with a Reduction in the Incidence of Perioperative Mortality and Nonfatal Myocardial infarction in Patients Undergoing Abdominal Aortic Aneurysm SurgeryEuropean Journal of Vascular and Endovascular Surgery, 2004
- Plasma Natriuretic Peptide Levels and the Risk of Cardiovascular Events and DeathNew England Journal of Medicine, 2004
- Myocardial infarction redefined—a consensus document of The Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarctionJournal of the American College of Cardiology, 2000
- Assessment of cardiac risk before nonvascular surgeryJournal of the American College of Cardiology, 2000
- Biochemical detection of left-ventricular systolic dysfunctionThe Lancet, 1998
- Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide.JCI Insight, 1991
- Perioperative Cardiac MorbidityAnesthesiology, 1990
- A new natriuretic peptide in porcine brainNature, 1988
- Epidural Anesthesia and Analgesia in High-risk Surgical PatientsAnesthesiology, 1987